These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 11422762)

  • 1. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy.
    Hovind P; Tarnow L; Rossing P; Carstensen B; Parving HH
    Kidney Int; 2004 Sep; 66(3):1180-6. PubMed ID: 15327415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of diabetic nephropathy.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Feb; 59(2):702-9. PubMed ID: 11168952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH; Hommel E; Jensen BR; Hansen HP
    Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of nephrotic-range albuminuria in type 1 diabetic patients.
    Hovind P; Rossing P; Tarnow L; Toft H; Parving J; Parving HH
    Diabetes Care; 2001 Nov; 24(11):1972-7. PubMed ID: 11679467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking and progression of diabetic nephropathy in type 1 diabetes.
    Hovind P; Rossing P; Tarnow L; Parving HH
    Diabetes Care; 2003 Mar; 26(3):911-6. PubMed ID: 12610058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy.
    Hansen HP; Christensen PK; Tauber-Lassen E; Klausen A; Jensen BR; Parving HH
    Kidney Int; 1999 Feb; 55(2):621-8. PubMed ID: 9987086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
    Parving HH; Rossing P; Hommel E; Smidt UM
    Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
    Hansen HP; Nielsen FS; Rossing P; Jacobsen P; Jensen BR; Parving HH
    Kidney Int Suppl; 1997 Dec; 63():S49-53. PubMed ID: 9407421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
    Rossing P; Hommel E; Smidt UM; Parving HH
    Kidney Int Suppl; 1994 Feb; 45():S145-9. PubMed ID: 8158884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
    Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
    J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission and regression of diabetic nephropathy.
    Hovind P; Tarnow L; Parving HH
    Curr Hypertens Rep; 2004 Oct; 6(5):377-82. PubMed ID: 15341691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
    Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH
    Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
    Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy.
    Parving HH; Smidt UM; Hommel E; Mathiesen ER; Rossing P; Nielsen F; Gall MA
    Am J Kidney Dis; 1993 Jul; 22(1):188-95. PubMed ID: 8322782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment.
    Parving HH; Andersen AR; Smidt UM; Christiansen JS; Oxenbøll B; Svendsen PA
    Diabetes; 1983 May; 32 Suppl 2():83-7. PubMed ID: 6400672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure reduction as a preventive treatment of diabetic nephropathy.
    Ribstein J; Mimran A
    Clin Invest Med; 1991 Dec; 14(6):661-70. PubMed ID: 1794216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
    Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.